Immunoqure Ag

Syeda F Y Haque

Mike Rothe

Annalisa Macagno

Adrian Hayday

Kai Krohn

Kai Kisand

Paert Peterson

Martin Woodward

Steffen Meyer

Philip Vlaicu

Shimobi Onuoha

Pärt Peterson

Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-α antibodies as well as IFN-α binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Human anti-IFN-α antibodies

Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.

CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody

Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-&#x3b1; antibodies as well as IFN-&#x3b1; binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Human anti-IFN-&#x3b1; antibodies

Human anti-IL-32 antibodies and methods of making and using the same

Growing community of inventors

London, United Kingdom

Syeda F Y Haque